Heron Therapeutics, Inc. (HRTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Heron Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -10.73x | -17.18x | -2.12x | -1.50x | -4.07x | -8.45x |
| P/B Ratio | 15.12x | -6.93x | -6.91x | 20.08x | 11.59x | 8.12x |
| P/S Ratio | 1.40x | 1.62x | 1.85x | 2.53x | 10.41x | 21.68x |
| Profitability | ||||||
| Gross Margin | 73.3% | 73.2% | 48.8% | 49.0% | 46.7% | 59.2% |
| Operating Margin | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% | -257.4% |
| Net Margin | -13.0% | -9.4% | -87.0% | -169.1% | -255.6% | -256.4% |
| EBITDA Margin | -11.5% | -3.5% | -81.7% | -164.1% | -249.3% | -251.1% |
| Liquidity | ||||||
| Current Ratio | 2.48x | 2.29x | 2.37x | 2.49x | 3.58x | 3.07x |
| Quick Ratio | 1.51x | 1.70x | 1.84x | 1.83x | 2.90x | 2.66x |
| Leverage | ||||||
| Debt/Equity | 9.81x | -5.28x | -5.29x | 11.60x | 2.06x | 0.10x |
YoY = year-over-year change. Source: FMP..